Quince Therapeutics Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 43 institutions reported holding Quince Therapeutics Inc. in their 13F filings, down 3 from Q1 2024. 2 opened new positions and 5 sold out. The largest holders were Tang Capital Management LLC ($1.1M), Vanguard Group Inc. ($911K) and EPIQ Capital Group, LLC ($639K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $262K |
| Exits | 5 | $133K |
All 13F filers, Q1 2024 → Q2 2024: 620,357 shares bought and 1,644,884 shares sold, net −1,024,527 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Tang Capital Management LLC | 0.11% | Reduce -49.1% | 1,500,000 | $1.1M |
| Vanguard Group Inc. | 0.00% | Add +7.3% | 1,214,621 | $911K |
| EPIQ Capital Group, LLC | 0.23% | Add +0.8% | 852,361 | $639K |
| Renaissance Technologies | 0.00% | Reduce -7.0% | 483,902 | $363K |
| BlackRock Inc. | 0.00% | Add +6.8% | 354,788 | $266K |
| HighTower Advisors, LLC | 0.00% | New | 341,570 | $251K |
| Geode Capital Management, LLC | 0.00% | Add +2.3% | 272,955 | $205K |
| Alphabet Inc. | 0.01% | No change | 189,122 | $142K |
| Bank of America Corp. | 0.00% | Reduce -7.0% | 157,972 | $118K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 138,495 | $104K |
| Citadel Advisors | 0.00% | Add +277.4% | 99,844 | $75K |
| Susquehanna International Group, LLP | 0.00% | Add +1.9% | 98,603 | $74K |
| Two Sigma Advisers, LP | 0.00% | Reduce -3.6% | 93,600 | $70K |
| ADAR1 Capital Management, LLC | 0.01% | Add +246.5% | 92,958 | $70K |
| Mariner, LLC | 0.00% | No change | 74,074 | $56K |
| State Street Corp. | 0.00% | No change | 56,611 | $42K |
| Intellectus Partners, LLC | 0.01% | Reduce -0.8% | 53,312 | $40K |
| Millennium Management | 0.00% | Reduce -31.9% | 36,567 | $27K |
| Northern Trust Corp. | 0.00% | Reduce -0.2% | 34,023 | $26K |
| Kestra Advisory Services, LLC | 0.00% | Add +18.6% | 15,359 | $12K |
| XTX Topco Ltd | 0.00% | New | 14,077 | $11K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $8K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 11,013 | $8K |
| Orion Porfolio Solutions, LLC | 0.00% | No change | 10,136 | $8K |
| Orion Portfolio Solutions, LLC | 0.00% | No change | 10,136 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.1% | 9,618 | $7K |
| Morgan Stanley | 0.00% | Add +1.4% | 8,522 | $6K |
| Citigroup Inc. | 0.00% | No change | 5,165 | $4K |
| Group One Trading LLC | 0.00% | Reduce -0.5% | 1,600 | $1K |
| Simplex Trading, LLC | 0.00% | Reduce -55.4% | 2,101 | $1K |
| UBS Group AG | 0.00% | Reduce -5.0% | 480 | $360 |
| JPMorgan Chase & Co. | 0.00% | No change | 469 | $352 |
| CoreCap Advisors, LLC | 0.00% | No change | 431 | $323 |
| Rhumbline Advisers | 0.00% | No change | 394 | $295 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $255 |
| Financial Perspectives, Inc | 0.00% | No change | 310 | $233 |
| Parallel Advisors, LLC | 0.00% | Reduce -5.1% | 295 | $221 |
| Osaic Holdings, Inc. | 0.00% | No change | 277 | $207 |
| Barclays PLC | 0.00% | No change | 100 | $75 |
| Financial Avengers, Inc. | 0.00% | No change | 100 | $75 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $56 |
| BNP Paribas Financial Markets | 0.00% | No change | 24 | $18 |
| Royal Bank of Canada | 0.00% | Add +26.2% | 279 | $0 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.